Skip to content
HNGE

Hinge Health, Inc.

Hinge Health, Inc. Q3 FY2025 earnings call

November 4, 2025 · fiscal period ended 2025-09

EPS · actual vs est

$0.34 / $0.24Beat +41.7%

Revenue · actual vs est

$154.2M / $156.8MMiss -1.6%
Ask about this call

Summary

Generated 2025-11-04

Management highlights

Product Updates

  • AI Initiatives: Introduced AI care assistant Robin, which provides 24/7 support to members, and a new movement analysis capability using TrueMotion Computer Vision for objective joint health tracking. AI is also being used to drive efficiency across the organization, with increased code output and improved developer experience.
  • Sales Season and HingeSelect: Sales season is progressing well with 2,560 contracted clients, up 25% Y/Y. HingeSelect, a high-performance provider network, went live with initial clients, has over 3,300 contracted provider locations, and 86% of lives live within its footprint.
  • Financial Efficiency: Operational efficiency improved with gross margin up and operating expenses down as a percentage of revenue, leading to strong profitability and free cash flow.
View in transcript ↓

Segment performance

In Q3, Hinge Health achieved $154 million in revenue, representing 53% year-over-year growth. LTM calculated billings reached $624 million, up 50% from the same period last year. Gross margin was 83% in Q3, up from 79% in Q3 of the prior year. Operating margin was 20%, a significant improvement from -4% in Q3 last year. Free cash flow for the quarter was $81 million, with a free cash flow margin of 53%.

View in transcript ↓

Guidance

Guidance

  • Q4 2025: Revenue expected to be in the range of $155 million to $157 million, representing 33% Y/Y growth at the midpoint. Non-GAAP income from operations projected at $34 million to $36 million.
  • Full Year 2025: Raised revenue guidance to $572 million to $574 million (up from prior range), with non-GAAP income from operations expected at $106 million to $108 million. Driven by strong core business fundamentals, billings performance, and operational efficiency gains from AI initiatives.
View in transcript ↓

Risks

Risks

  • Concerns from health plan partners, employers, etc., regarding AI in health care due to high stakes in health care. However, Hinge Health is focused on bread-and-butter AI applications to address these concerns.
  • Government shutdown impact on federal business, but currently, no material impact has been seen as federal business is performing strongly.
View in transcript ↓

Q&A highlights

Q: How is Hinge balancing AI innovation with concerns from health plan partners about data?

A: Hinge Health has published AI care principles guiding development, focusing on responsible AI use, privacy, security, transparency, and continuous improvement, and involves partners in roadmaps and outcomes.

Q: How is the federal government shutdown affecting Hinge's business?

A: There has been no impact so far, and federal business is performing as strong as ever.

Q: Can you elaborate on the targeted enrollment initiatives driving yield outperformance?

A: Targeted enrollment has seen a 2x Y/Y increase, driven by data collaboration with health plans, real-time data ingestion, and standardized data use to identify and enroll high-risk members.

Q: How are AI initiatives impacting operating expenses?

A: AI has contributed to improvements, with about half of the 2,600 basis points of margin improvement coming from AI advances, including more efficient processes and deployment.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.34$0.24+41.7%
Revenue$154.2M$156.8M-1.6%

Transcript

November 4, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.